Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente BMC CANCER

Tipo Año Título Fuente
Artículo2022Determination of essential biomarkers in lung cancer: a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristicsBMC CANCER
Artículo2022GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastasesBMC CANCER
Artículo2022Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) studyBMC CANCER
Artículo2021Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life dataBMC CANCER
Artículo2020Clinical performance evaluation of the Idylla (TM) EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancerBMC CANCER
Artículo2020Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancerBMC CANCER
Artículo2019Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancerBMC CANCER
Artículo2018Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 CountriesBMC CANCER
Artículo2018Advanced sporadic renal epithelioid angiomyolipoma: Case report of an extraordinary response to sirolimus linked to TSC2 mutationBMC CANCER
Artículo2016Colorectal cancer health services research study protocol: The CCR-CARESS observational prospective cohort projectBMC CANCER
Artículo2014MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancerBMC CANCER
Artículo2011Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancersBMC CANCER
Artículo2008Methylation alterations are not a major cause of PTTG1 missregulationBMC CANCER